Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2671 AL 2685

Satisfaction With Telemedicine Consultation as Follow-Up Visit in Patients with Parkinsonism and Essential Tremor in during the Covid-19 Pandemic

Mayela RV, Yamil M, Amin CA, Yazmín RS, Arturo AC, Daniel MR, Lorena ZV, Karla SB, Manuel DRQ.

Neurol India. 2022 Sep-Oct;70(5):2003-2008. doi: 10.4103/0028-3886.359193.

Successful radiofrequency catheter ablation of Wolff-Parkinson-White syndrome in a patient with dextrocardia: A case report

Zhao L, Li R, Bai L, Wang D, Zhang J, Yang X.

Front Cardiovasc Med. 2022 Oct 24;9:1006435. doi: 10.3389/fcvm.2022.1006435. eCollection 2022.

Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses

Rastogi S, Singh A.

Front Pharmacol. 2022 Oct 24;13:1042189. doi: 10.3389/fphar.2022.1042189. eCollection 2022.

Single-cell and single-nuclei RNA sequencing as powerful tools to decipher cellular heterogeneity and dysregulation in neurodegenerative diseases

Cuevas-Diaz Duran R, González-Orozco JC, Velasco I, Wu JQ.

Front Cell Dev Biol. 2022 Oct 24;10:884748. doi: 10.3389/fcell.2022.884748. eCollection 2022.

Beneficial effects of natural flavonoids on neuroinflammation

Chen Y, Peng F, Xing Z, Chen J, Peng C, Li D.

Front Immunol. 2022 Oct 24;13:1006434. doi: 10.3389/fimmu.2022.1006434. eCollection 2022.

The Neuroepigenetic Landscape of Vertebrate and Invertebrate Models of Neurodegenerative Diseases

Sundaramoorthy TH, Castanho I.

Epigenet Insights. 2022 Nov 4;15:25168657221135848. doi: 10.1177/25168657221135848. eCollection 2022.

Older patients with COVID-19 and neuropsychiatric conditions: A study of risk factors for mortality

Nguyen-Michel VH, Houot M, Delorme C, Sangaré A, Gales A, Frazzini V, Hanin A, Aissani D, Trân T, Oquendo B, Ketz F, Lafuente-Lafuente C, Oasi C, Kinugawa K, Ouvrard G, Ursu R, Degos B, Rohaut B, Demeret S, Lambrecq V, Navarro V, Fournier E, Corvol JC, Borden A.

Brain Behav. 2022 Dec;12(12):e2787. doi: 10.1002/brb3.2787. Epub 2022 Nov 10.

Closed loop deep brain stimulation: A systematic scoping review

Cuschieri A, Borg N, Zammit C.

Clin Neurol Neurosurg. 2022 Dec;223:107516. doi: 10.1016/j.clineuro.2022.107516. Epub 2022 Nov 6.

Protein misfolding and related human diseases: A comprehensive review of toxicity, proteins involved, and current therapeutic strategies

Khan AN, Khan RH.

Int J Biol Macromol. 2022 Dec 31;223(Pt A):143-160. doi: 10.1016/j.ijbiomac.2022.11.031. Epub 2022 Nov 8.

Effects of Anti-Parkinsonian Drugs on Verbal Fluency in Patients with Parkinson's Disease: A Network Meta-Analysis

Zhu Y, Li S, Lai H, Mo L, Tan C, Liu X, Deng F, Chen L.

Brain Sci. 2022 Nov 4;12(11):1496. doi: 10.3390/brainsci12111496.

Neurodegenerative Microbially-Shaped Diseases: Oxidative Stress Meets Neuroinflammation

Silva DF, Empadinhas N, Cardoso SM, Esteves AR.

Antioxidants (Basel). 2022 Oct 28;11(11):2141. doi: 10.3390/antiox11112141.

LRRK2 and Lipid Pathways: Implications for Parkinson's Disease

Galper J, Kim WS, Dzamko N.

Biomolecules. 2022 Oct 30;12(11):1597. doi: 10.3390/biom12111597.

Immunosenescence in Neurological Diseases-Is There Enough Evidence?

Rommer PS, Bsteh G, Zrzavy T, Hoeftberger R, Berger T.

Biomedicines. 2022 Nov 9;10(11):2864. doi: 10.3390/biomedicines10112864.

A Computerized Analysis with Machine Learning Techniques for the Diagnosis of Parkinson's Disease: Past Studies and Future Perspectives

Rana A, Dumka A, Singh R, Panda MK, Priyadarshi N.

Diagnostics (Basel). 2022 Nov 5;12(11):2708. doi: 10.3390/diagnostics12112708.

Nanomedicine in the Face of Parkinson's Disease: From Drug Delivery Systems to Nanozymes

Padilla-Godínez FJ, Ruiz-Ortega LI, Guerra-Crespo M.

Cells. 2022 Oct 31;11(21):3445. doi: 10.3390/cells11213445.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias